SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13E3 - Going private transaction by certain issuers:
SEC Accession No. 0000950135-96-004126
Filing Date
1996-09-27
Accepted
1996-09-27 00:00:00
Documents
4
Group Members
GENZYME CORPNEOZYME II ACQUISITION CORP.NEOZYME II CORPORATION
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 NEOZYME II AND GENZYME CORPORATION SC 13E3 36578
2 REPORT OF ROBERTSON, STEPHENS & COMPANY LLC EX-99.B1 158424
3 REPORT OF HAMBRECHT & QUIST LLC EX-99.B3 119934
4 AUDITED FINANCIAL STATEMENTS EX-99.G1 40656
  Complete submission text file 0000950135-96-004126.txt   357996
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filed by) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE KENDALL SQUARE BRIDGE MA 02139
Business Address TODMAN BLDG MAIN ST ROAD TOWN TORTOLA BRITISH VIRG D8 8094942065
NEOZYME II CORP (Subject) CIK: 0000884392 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13E3 | Act: 34 | File No.: 005-42416 | Film No.: 96635877
SIC: 2836 Biological Products, (No Diagnostic Substances)